Pharma Parenteral Packaging Market Size is valued at USD 13.28 Bn in 2023 and is predicted to reach USD 18.85 Bn by the year 2031 at a 4.47% CAGR during the forecast period for 2024-2031.
Pharma parenteral packaging describes the unique techniques developed for storing and administering sterile pharmaceuticals through infusion, intramuscular, or epidermal injections rather than the digestive tract. These packaging techniques guarantee that the product will remain intact, sterile, and safe throughout its entire lifecycle, from storage to transit to administration. The growing prevalence of chronic diseases and injectable drug usage, growing focus on improving patient safety, rising use of biologics, and growing use of prefilled syringes and injection devices are expected to lead to an increase in the need for pharma parenteral packaging solutions and support the growth of the market.
However, the market growth is estimated to be hampered by the stringent government regulations and standards and, the cost of raw materials used in pharma parenteral packaging.
Competitive Landscape
Some Major Key Players In The Pharma Parenteral Packaging Market:
- Adelphi Healthcare Packaging
- Akorn, Inc.
- Alcami Corporation, Inc.
- Ardena Holding NV
- Baxter International Inc.
- Becton, Dickinson and Company
- Berkshire Sterile Manufacturing
- Berry Global Inc.
- Catalent Inc.
- Gerresheimer AG.
- Nipro Corporation
- PCI Pharma Services
- Schott AG
- SGD Pharma
- SiO2 Materials Science.
- Stevanato Group S.p.A
- Terumo Corporation
- UDG Healthcare Plc.
- West Pharmaceutical Services, Inc.
- Ypsomed Holding AG
Market Segmentation:
The pharma parenteral packaging market is segmented based on drug type, product type, packaging type and material. Based on drug type, the market is segmented into small molecules, biologics, vaccines, and biosimilars. By product type, the market is segmented into bottles, ampoules, vials, prefilled syringes, and cartridges. By material, the market is segmented into glass, polymer, PVC, and others. By packaging type, the market is segmented into small-volume parenteral and large-volume parenteral.
Based on the Product Type, the Prefilled Syringes Segment is Accounted as a Major Contributor to the Pharma Parenteral Packaging Market
The prefilled syringes pharma parenteral packaging market is expected to hold a significant global market share in 2024. Ease of use of prefilled syringes, preference for small molecules in prefilled syringes over other dosage forms, lower dosage errors and growing demand for prefilled insulin syringes due to increasing cases of diabetes are driving growth in pharma parenteral packaging globally.
Glass segment to witness growth at a rapid rate
The glass industry makes up the bulk of pharma parenteral packaging because Glass is used for various purposes and can be found in many different goods. It is a commonly utilized raw material in parenteral packaging due to its impermeable and non-porous nature, which allows it to retain product composition. Glass also protects items from ultraviolet radiation, which means they stay fresh for longer, especially in countries like the US, Germany, the U.K., China, and India.
In the region, the North American Pharma Parenteral Packaging Market Holds a Significant Revenue Share.
The North American pharma parenteral packaging market is expected to register the highest market share in revenue in the near future. This can be attributed to the presence of prominent parenteral packaging businesses, the increasing need for injectable medication packaging, and the pharmaceutical industry's overall growth. In addition, Asia Pacific region is projected to grow at the highest growth rate during study period because of the increasing incidence of chronic and infectious diseases, the growing need for pharmaceutical vial packaging, and the rise in vaccination programs.
Recent Developments:
- In January 2024, SCHOTT Pharma expanded its global manufacturing network and invested a double-digit million euros in a new production site for pharma drug containment solutions and delivery systems in Jagodina in central Serbia.
- In October 2023, Gerresheimer launched COP (Cyclic Olefin Polymer) to fill and store sensitive biopharmaceutical mRNA active ingredients.
- In 2023, B.D. introduced the all-in-one prefilled flush syringe with an integrated disinfection unit.
Pharma Parenteral Packaging Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 13.28 Bn |
|
Revenue Forecast In 2031 |
USD 18.85 Bn |
|
Growth Rate CAGR |
CAGR of 4.47% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn, Volume (Tons) and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Drug Type, By Product Type, By Material, By Packaging Type |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Adelphi Healthcare Packaging, Akorn, Inc., Alcami Corporation, Inc., Ardena Holding NV, Baxter International Inc., Becton, Dickinson and Company, Berkshire Sterile Manufacturing, Berry Global Inc., Catalent Inc., Gerresheimer AG., Nipro Corporation, PCI Pharma Services, Schott AG, SGD Pharma, SiO2 Materials Science., Stevanato Group S.p.A, Terumo Corporation, UDG Healthcare Plc., West Pharmaceutical Services, Inc., Ypsomed Holding AG |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your specific requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
